News

Advancing a new era of breakthrough biomedical discoveries

For media requests, please contact press@dnastack.com.

News
November 7, 2024

DNAstack Introduces Instruments at ASHG 2024

DNAstack announces the launch of Instruments, a new feature that streamlines genomic data analysis in the cloud through direct integration with sequencing instruments. Revealed at the American Society of Human Genetics (ASHG) Annual Meeting in Denver, Instruments makes it easier and faster for scientists to go from sequences to solves.
Press Releases
September 11, 2024

PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific

The HiFi Solves Sub-fertility Consortium integrates DNAstack’s federated data platform, the world’s first solution to enable the creation and analysis of global federated networks of data in compliance with industry standards set by the Global Alliance for Genomics & Health.
News
June 25, 2024

DNAstack Partners with The Michael J. Fox Foundation and ASAP to Uncover the Roots of Parkinson’s Disease

The Aligning Science Across Parkinson’s (ASAP) initiative has collaborated with DNAstack, The Michael J. Fox Foundation, Verily, and DataTecnica to launch the ASAP Collaborative Research Network Cloud. This platform, powered by DNAstack’s Omics AI, serves to unite data analysis efforts across the global research community and accelerate the path for a cure to Parkinson’s.
News
June 17, 2024

DNAstack Wins Health Privacy Leadership Award

As AI evolves to deliver more powerful experiences by learning from our data, it is important to implement safeguards that ensure we are protecting personal privacy. By building AI with strict requirements around the protection of personal privacy, we can develop new technologies in a safe, ethical, and responsible way for the benefit of society.
News
May 16, 2024

World’s Largest Autism Genome Database Expands

Autism Speaks’ MSSNG database, the world’s largest autism whole-genome dataset powered by DNAstack software, recently expanded to include an additional 2,489 fully sequenced genomes in the project’s cloud-based dataset. Genomic data is now available for 13,801 individuals, including over 6,000 autistic people and over 7,000 of their family members.

News
May 14, 2024

Target ALS and DNAstack Expand Network By Connecting New Natural History Study

Target ALS, a nonprofit organization that breaks down barriers to accelerate research for Amyotrophic Lateral Sclerosis (ALS), has added a Natural History Study Collection to their recently launched data platform powered by Omics AI. The platform provides no-strings-attached access to comprehensive datasets and analysis tools to fuel discovery of treatments and biomarkers for ALS.

News
April 16, 2024

DNAstack Announces Partnership on AI with Vector Institute

DNAstack is proud to announce its Bronze sponsorship with the Vector Institute, a globally-renowned AI Institute that empowers researchers, businesses and governments, to develop and adopt AI responsibly. This union between industry and academia will serve to amplify the shared goal of accelerating AI-based innovation in Canada.
Video
April 3, 2024

The Future is Federated

In this seminar hosted by Australian Genomics, in discussion with Managing Director Tiffany Boughtwood, DNAstack CEO Marc Fiume covers the latest in genomics and health data standards, interoperability, federated insights, and AI that when combined together can enable breakthrough discoveries in precision health.
News
April 2, 2024

DNAstack Partners with Target ALS to Launch Groundbreaking Data Platform

Target ALS, a nonprofit organization that breaks down barriers to accelerate research for Amyotrophic Lateral Sclerosis (ALS), has launched a first-of-its-kind data portal to provide no-strings-attached access to comprehensive datasets and analysis tools to fuel discovery of treatments and biomarkers for ALS.

News
January 15, 2024

DNAstack announces a new ISO standard, Requirements for interoperable systems for genomic surveillance

Today, we’re excited to announce a new ISO standard, Requirements for interoperable systems for genomic surveillance.Genomic surveillance combined with rapid realtime data sharing is the most important tool we have for detecting and stopping the spread of infectious diseases, like COVID.

News
October 11, 2023

DNAstack launches Workflows marketplace to unify omics analysis

Workflows makes it easier and safer for scientists to discover and run trusted, high-quality, reproducible computational pipelines for analyzing omics data. The marketplace includes a curated collection of best practices pipelines for processing data from popular sequencing instrument manufacturers, including PacBio, Illumina, and Oxford Nanopore. Workflows integrates with Workbench, a workflow execution manager by DNAstack, unifying the experience of performing omics data analyses across multiple sequencing instruments and cloud computing platforms.
News
September 20, 2023

DNAstack launches Omics AI to power insights from global federated networks

Toronto, Ontario — DNAstack today launched Omics AI, a revolutionary new software suite for omics and health research.

Omics AI makes scientific discoveries faster and more powerful by enabling insights across federated networks of data, in compliance with open standards by the Global Alliance for Genomics & Health (GA4GH). The system is being used by world leading pharmaceutical companies, hospitals, universities, patient advocacy groups, funders, sequencing facilities, government agencies, and consortiums to grow collaborative networks in diverse areas of research.

Podcast
August 21, 2023

Genomics in the Cloud Podcast

DNAstack CEO Dr. Marc Fiume speaks with Geraldine Van der Auwera and Michael de la Maza about the company's products and vision for the future of genomics and health research.
News
June 30, 2023

DNAstack Accepts LSO Company of the Year 2023 Award

DNAstack CEO Marc Fiume accepts the LSO Company of the Year Award, introduced by Dr. Catalina Lopez-Correa, CSO at Genome Canada.
News
May 2, 2023

DNAstack launches Neuroscience AI to accelerate collaborative research and discovery

Neuroscience AI will enable researchers to make discoveries from larger and more diverse datasets than ever before.

Toronto, Ontario — DNAstack and partners today launched Neuroscience AI, a new federated platform for collaborative neuroscience research. By enabling privacy-preserving AI-powered insights across distributed networks of data, Neuroscience AI will enable researchers to make discoveries from larger and more diverse datasets than ever before. The platform is being used to advance collaborative research in autism by connecting global members of the Autism Sharing Initiative.

News
April 7, 2023

DNAstack to lead expansion of Canadian platform for federated AI-powered insights in genomics and precision health

The new project will help expand federated, AI-powered insights across distributed networks of genomics and health data. 

Toronto, Ontario — Today, a Canadian consortium led by DNAstack is announcing the launch of a new project to expand the development of a software platform to enable federated, AI-powered insights across networks of genomics and health data. The Canadian Platform for Genomics & Precision Health (CP4GPH) is a $14.5M initiative co-funded by Digital that brings together domain experts with a shared vision to deliver better outcomes for Canadians by making it easier to connect and analyze exponentially growing volumes of distributed genomics and health data. The project builds upon the multi-award-winning software platform developed by its partners as part of previous collaborations.

News
February 10, 2023

DNAstack named Company of the Year by Life Sciences Ontario

Award recognizes Toronto company’s global impact on genomics and health research.Toronto, Ontario — Today DNAstack was named 2023 Company of the Year by Life Sciences Ontario (LSO). The award celebrates DNAstack’s breakthrough software platform, which enables AI-powered insights across distributed genomics and health data. The platform is being used to support global pandemic surveillance and to advance better outcomes in neuroscience, oncology, and rare disease. The LSO Company of the Year award is given to an outstanding Ontario-based company that has demonstrated strong leadership in advancing innovative technology in the life sciences.
Press Releases
November 16, 2022

Pacific Biosciences Says More Sequencers in Development Pipeline, Outlines Future Growth Plans

David Miller, PacBio VP of product marketing, highlighted the company’s partnerships, including with Hamilton, Miroculus, the Broad Institute, Twist Biosciences, Google Health, DNAnexus, and DNAstack, for various companion offerings to enhance its sequencing workflow.

Press Releases
November 14, 2022

Genomic architecture of autism from comprehensive whole-genome sequence annotation

Publication in Cell on the genomic architecture of autism from comprehensive genomic analysis of over 11,000 individuals.
Video
September 28, 2022

A Vision for an Internet for Pandemic Surveillance

DNAstack CEO Marc Fiume presents a vision for an Internet for Pandemic Surveillance at the 10th Plenary Meeting of the Global Alliance for Genomics & Health (GA4GH) in Barcelona, Spain.

Top